Nicholas Williams’ Post

Is your clinical trial process 𝘀𝘁𝘂𝗰𝗸 𝗶𝗻 𝗻𝗲𝘂𝘁𝗿𝗮𝗹? It's time to 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲. 𝗥𝗲𝘃𝗮𝗺𝗽 𝗬𝗼𝘂𝗿 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝘄𝗶𝘁𝗵 𝗜𝗤𝗩𝗜𝗔 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗗𝗮𝘆 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝗘𝘂𝗿𝗼𝗽𝗲 2024𝗅 Join us at the 𝗜𝗤𝗩𝗜𝗔 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗗𝗮𝘆 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝗘𝘂𝗿𝗼𝗽𝗲 2024 for a complimentary afternoon of game-changing insights and solutions. 𝗛𝗲𝗿𝗲'𝘀 𝘄𝗵𝗮𝘁 𝗮𝘄𝗮𝗶𝘁𝘀 𝘆𝗼𝘂: 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗘𝗱𝗴𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Get a glimpse into the future of clinical research with presentations from IQVIA's digital product leaders. 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗗𝗲𝗺𝗼𝘀: Experience firsthand how IQVIA's innovative technologies can streamline your workflows, improve patient engagement, and boost site efficiency. 𝗢𝗽𝗲𝗻 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: Challenge industry experts with your questions and learn from the experiences of your peers at the "𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗙𝗼𝗿𝘂𝗺." 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀: Connect with other clinical trial professionals, build meaningful relationships, and explore potential collaborations. 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗶𝗱𝗲𝗮𝗹 𝗳𝗼𝗿: Pharmaceutical executives Trial managers Medical directors Business operations professionals Patient or site engagement specialists Strategic sourcing leads Register today for IQVIA Innovation Day at SCOPE Europe 2024: https://lnkd.in/gqA9ZnwB hashtag #IQVIAInnovationDay hashtag #SCOPEEurope hashtag #ClinicalTrials hashtag #Innovation hashtag #ClinicalOperations hashtag #Networking

We are excited to introduce our 2024 Diamond Sponsor, IQVIA – a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry! 💎 💎 IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. ❤️🩹⚕️ Meet the IQVIA team in person on the #WorldDrugSafety expo floor, coming to the Boston Convention & Exhibition Center next month. Book your group & 𝐬𝐚𝐯𝐞 𝐮𝐩 𝐭𝐨 𝟓𝟎% 𝐨𝐧 𝐭𝐢𝐜𝐤𝐞𝐭𝐬 with our new discounted group rate ➡️ https://lnkd.in/gqpN6izz + 𝐾𝑒𝑒𝑝 𝑟𝑒𝑎𝑑𝑖𝑛𝑔 𝑡𝑜 𝑙𝑒𝑎𝑟𝑛 𝑚𝑜𝑟𝑒 𝑎𝑏𝑜𝑢𝑡 𝑜𝑢𝑟 𝑑𝑖𝑎𝑚𝑜𝑛𝑑 𝑠𝑝𝑜𝑛𝑠𝑜𝑟 𝑏𝑒𝑙𝑜𝑤 ⬇️ IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. #DrugSafety #MedicalTreatments #Pharmacovigilance #Biotech #MedicalDevice #Pharmaceutical #MedicalResearchers #PV #ClinicalDevelopment #Healthcare

🚨 Why Do Drug Launches Fail? 🚨 Launching a drug successfully is no easy task—many launches face unexpected pitfalls. Join us for an insightful FREE webinar on October 17, 2024, at 1 PM EST where we'll explore the most common reasons behind failed drug launches and strategies to ensure success. 💡 What you’ll learn: - Key strategic pitfalls to avoid in drug launches. - Cross-functional collaboration tips for Medical Affairs, Market Access, and beyond. - Real-world case studies of failed and successful launches with actionable takeaways. - Best practices for mitigating risk and ensuring stakeholder engagement. 🎤 Meet the Speakers: - Ebtehal Madi, BCMAS – Global Medical Collaboration Network Enabler, with deep expertise in product launches and scientific communication. - James “Steve” Fields, PACS – VP, Field Access & Reimbursement at Inizio Engage, with 16+ years of leadership in market access and patient services. Don’t miss out—register now and secure your spot: https://lnkd.in/gA4Xq3QV #acma #bcmas #pacs #pharma #druglaunch #marketaccess #medicalaffairs #webinar #patientaccess #biopharma

🚨 Why Do Drug Launches Fail? 🚨 Launching a drug successfully is no easy task—many launches face unexpected pitfalls. Join us for an insightful FREE webinar on October 17, 2024, at 1 PM EST where we'll explore the most common reasons behind failed drug launches and strategies to ensure success. 💡 What you’ll learn: - Key strategic pitfalls to avoid in drug launches. - Cross-functional collaboration tips for Medical Affairs, Market Access, and beyond. - Real-world case studies of failed and successful launches with actionable takeaways. - Best practices for mitigating risk and ensuring stakeholder engagement. 🎤 Meet the Speakers: - Ebtehal Madi, BCMAS – Global Medical Collaboration Network Enabler, with deep expertise in product launches and scientific communication. - James “Steve” Fields, PACS – VP, Field Access & Reimbursement at Inizio Engage, with 16+ years of leadership in market access and patient services. Don’t miss out—register now and secure your spot: https://lnkd.in/eEzeyCFg #acma #bcmas #pacs #pharma #druglaunch #marketaccess #medicalaffairs #webinar #patientaccess #biopharma

Over my career I’ve been involved in 20+ launches. Join us to take a look at common pitfalls and how to steer around them. #frm #marketaccess #patientsupport #patientaccess.

🚨 Why Do Drug Launches Fail? 🚨 Launching a drug successfully is no easy task—many launches face unexpected pitfalls. Join us for an insightful FREE webinar on October 17, 2024, at 1 PM EST where we'll explore the most common reasons behind failed drug launches and strategies to ensure success. 💡 What you’ll learn: - Key strategic pitfalls to avoid in drug launches. - Cross-functional collaboration tips for Medical Affairs, Market Access, and beyond. - Real-world case studies of failed and successful launches with actionable takeaways. - Best practices for mitigating risk and ensuring stakeholder engagement. 🎤 Meet the Speakers: - Ebtehal Madi, BCMAS – Global Medical Collaboration Network Enabler, with deep expertise in product launches and scientific communication. - James “Steve” Fields, PACS – VP, Field Access & Reimbursement at Inizio Engage, with 16+ years of leadership in market access and patient services. Don’t miss out—register now and secure your spot: https://hubs.ly/Q02SQvjt0 #acma #bcmas #pacs #pharma #druglaunch #marketaccess #medicalaffairs #webinar #patientaccess #biopharma

🔍 Just read an eye-opening article uncovering the keys to Market Access Excellence in pharma and life sciences. Here's a sneak peek into the strategic insights it offers: 🔹 Strategic and collaborative evidence generation planning is crucial for demonstrating asset value throughout the product lifecycle. 🔹 Inadequate evidence understanding can lead to limited reimbursement and access, emphasizing the importance of cross-functional cooperation. 🔹 RCTs alone may not suffice for market access needs; integrating payer insights early is essential for success. 🔹 Investing in collaborative real-world evidence generation is vital for preserving R&D investments and accelerating patient access to treatment. ℹ️ Market Access Excellence goes beyond regulatory approval; it's about understanding stakeholder needs and adapting evidence generation strategies for success. Let's rethink how we approach evidence generation in the pharma industry! 🔗 https://lnkd.in/dibbv-AA

CRO ECOSYSTEM | NAVIGATING THE CRO SELECTION PROCESS: A GUIDE FOR SPONSORS   Choosing the right Contract Research Organization (CRO) is a pivotal decision for sponsors embarking on #clinicalstudies. With numerous options available, it's essential to navigate the selection process strategically. Here's a comprehensive guide to aid sponsors in making informed choices: Define Your Objectives: Begin by outlining your study's specific requirements and objectives. Understand your #timeline, #budget constraints, therapeutic area expertise needed, and desired level of #collaboration. Clarity at this stage sets the foundation for a successful partnership. Evaluate Expertise and Experience: Assess the #CRO's track record and #expertise in conducting studies similar to yours. Look for relevant therapeutic and geographical #experience, along with a demonstrated ability to meet regulatory standards and timelines. Quality and Compliance: Prioritize #quality and #compliance standards. Ensure the CRO adheres to Good Clinical Practice (GCP) guidelines and has robust quality management systems in place. Compliance with regulatory requirements is non-negotiable. Assess Team Capabilities: Evaluate the capabilities of the CRO's project management and operational teams. Effective communication, #proactive problem-solving, and a collaborative mindset are essential for seamless clinical study execution. Global Reach and Resources: Consider the CRO's #globalfootprint and resource capabilities. Assess their ability to access diverse patient populations, navigate regulatory landscapes, and provide comprehensive support across different regions. Technology and Innovation: Explore the CRO's technological infrastructure and #innovation capabilities. Look for expertise in implementing #digitalsolutions, data analytics, and risk-based monitoring approaches to enhance efficiency and data quality. Cultural Fit and Communication: Assess the cultural fit between your organization and the CRO. Effective communication, shared values, and a collaborative culture are vital for building a successful long-term #partnership. Continuous Evaluation: The selection process doesn't end after choosing a CRO. Continuously evaluate the partnership's progress, #performance metrics, and alignment with your evolving needs. Open dialogue and regular reviews ensure the partnership remains productive and aligned with your objectives. Navigating the CRO selection process requires thorough research, strategic thinking, and alignment with your study's objectives. At 3B Biotech Research, we ensure all these guidelines are met, enabling sponsors to forge a partnerships that drive successful clinical research outcomes and advance medical innovation. #ClinicalResearch #ClinicalTrials #Pharmaceuticals #Healthcare #CRO #CROExcellence

An exciting session to learn more on how to extract greater value from Evidence Generation activities for better Life-Cycle Management. Dr. Mahendra Kumar Rai #marketaccess #value

@ IQVIA Institute reports are a wealth of information on the global bio-pharmaceutical industry. Great for historical data and future trends